Benign Prostatic Hyperplasia Surgical Devices Market Insights

Benign prostate hyperplasia (BPH) refers to the non-cancerous enlargement of prostate. The treatment option depends on various factors such as age of the patient, prostate gland size, and severity of the disease. According to an article published in Urologic Clinic of North America, 2016, BPH is a common problem that affects over 20% of men in the U.S., which is around 15 million men. The treatment option includes medication, surgery such as open prostatectomy, transurethral resection of the prostate (TURP), and minimally invasive therapies such as transurethral needle ablation (TUNA) and minimally invasive therapies such as laser therapy, radiofrequency ablation, implants and others.

Increasing demand for minimally invasive therapies is expected to boost growth of the benign prostatic hyperplasia surgical devices market

Minimally invasive surgeries have gained traction in the recent past, owing to various advantages such as significant reduction in postoperative pain, decreased recovery time, reduced hospital stays, lesser surgical scars, laparoscopic incisions being safer than open incisions, equivalent or better safety, and efficacy in abdominal and general surgeries as compared to open surgeries, and these surgeries may be less expensive than open surgeries. Moreover, these therapies offer one-time permanent solution rather than long-time dependent on medications. Currently, more than 60% and 20% of patients suffering from benign prostatic hyperplasia is on drugs and under observation. The minimally invasive therapies are focusing on these groups particularly and have also witnessed some success in attracting such customers.

For instance, implant, manufactured by NeoTract, Inc., (now acquired by Teleflex Incorporated), which entered U.S. market in 2013-14 saw exponential revenue growth in last 2 years, 2015 and 2016. In first two quarters of 2017 alone, the revenue generated crossed the revenue generated in last year (i.e. 2016) and is expected to perform similar in remaining two quarters of the year.  By 2025, the revenue generated from implants may occupy nearly 40% share of the total benign prostatic hyperplasia surgical devices market, which is huge considering the recent introduction of products in market. There are other novel therapies, such as prostate artery embolization developed by Merit Medical Systems, Inc. and aquablation device developed by Procept BioRobotics, which demonstrated impressive therapeutic results in the clinical trials. These products with improved efficacy is expected to significantly enhance the adoption rate, in turn boosting the growth of the market.

The global benign prostatic hyperplasia surgical devices market was valued at US$ 375.9 million in 2016 and is expected to witness a robust CAGR of 7.5% over the forecast period (2017 – 2025).

Figure 1. Global Benign Prostatic Hyperplasia Surgical Devices Market (US$ Mn), by Region, 2016

Benign Prostatic Hyperplasia Surgical

   Source: Coherent Market Insights Analysis (2017)

Increasing geriatric population is expected to drive the growth of benign prostatic hyperplasia surgical devices market

Benign prostatic hyperplasia is the most common prostate problem in men aged 50 years and above and the occurrence of the same tends to increase with age. According to the U.S. Census Bureau, 2015, among 7.3 billion people worldwide, an estimated 617.1 million people were aged 65 years and older and the number of geriatric population is expected to increase above 60% by year 2030 indicating the potential population base associated with lower urinary tract symptoms (LUTS) resulting due to benign prostatic hyperplasia. According to the Population Reference Bureau, numbers of American aged 65 years and above are expected to reach up to 98 million by 2060, more than double from 2014 and will constitute about one-fourth of the total population. This increasing aging population presents immense market opportunity for companies, specifically start-ups working on novel therapies such as ProVerum Limited, ProArc Medical and Zenflow, and Others.

Some major players operating in the benign prostatic hyperplasia surgical devices market are Olympus Corporation, Boston Scientific Corporation, Medifocus Inc., KARL STORZ SE & Co. KG, NxThera, Inc., ProArc Medical, Lisa Laser Products OHG, and Richard Wolf Gmbh.

Benign prostatic hyperplasia (BPH) is a medical condition, which is characterized by non-cancerous enlargement of prostate and it generally affects men aged more than 50 years. According to the study published in The Lancet in 2015, more than 100 million people were suffering from benign prostatic hyperplasia (BPH) globally. Drugs such as Alpha- blockers and 5α-Reductase inhibitors (5ARIs), surgery such as transurethral resection of the prostate (TURP), and minimally invasive surgeries such as implants, radiofrequency ablation, and lasers are the primary treatment options available for the disease. As surgery and minimally invasive therapy offers permanent solution, the benign prostatic surgical devices market is expected to grow significantly during the forecast period.

Market Dynamics

Increasing demand for minimally invasive therapy such as implants, prostatic stents and laser therapy are expected to be primary driving force for this market. Although implant has entered very late in benign prostatic hyperplasia market, its demand is increasing. NeoTract, Inc. received the approval for first implant for benign prostatic hyperplasia in 2010 and 2013 in Europe and U.S. respectively. This huge transaction value underlines the market opportunity for such products in developed economies such as the U.S. and European economies in short-term period and globally in long-term period. Other novel treatment options such as prostatic artery embolization (PAE) has also gained traction in recent years and its application for benign prostatic hyperplasia treatment is expected to get streamlined in near future. The introduction of novel treatments options such as PAE is expected to lead to further growth in the market. Moreover, increasing aging population, which is more prone to the disease is expected to support the growth of this market. According to Population Reference Bureau, the number of American people aged 65 years and above is expected to more than double from 46 million in 2014 to 98 million by 2060.

Key features of the study:

  • This report provides in-depth analysis of benign prostatic hyperplasia surgical devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global benign prostatic hyperplasia surgical devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Olympus Corporation, Boston Scientific Corporation, Medifocus Inc., KARL STORZ SE & Co. KG, NxThera, Inc., ProArc Medical, Lisa Laser Products OHG, and Richard Wolf Gmbh
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global benign prostatic hyperplasia surgical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the benign prostatic hyperplasia surgical devices market

Detailed Segmentation:

  • Global Benign Prostatic Hyperplasia Surgical Devices Market, By Product Type:
    • Resectoscopes
    • Radiofrequency Ablation Devices
    • Urology Lasers
    • Prostatic Stents
    • Implants
    • Others
  • Global Benign Prostatic Hyperplasia Surgical Devices Market, By End User:
    • Hospitals
    • Ambulatory Surgery Centers
  • Global Benign Prostatic Hyperplasia Surgical Devices Market, By Geography:
    • North America
      • By Product Type:
        • Resectoscopes
        • Radiofrequency Ablation Devices
        • Urology Lasers
        • Prostatic Stents
        • Implants
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgery Centers
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type:
        • Resectoscopes
        • Radiofrequency Ablation Devices
        • Urology Lasers
        • Prostatic Stents
        • Implants
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgery Centers
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Resectoscopes
        • Radiofrequency Ablation Devices
        • Urology Lasers
        • Prostatic Stents
        • Implants
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgery Centers
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type:
        • Resectoscopes
        • Radiofrequency Ablation Devices
        • Urology Lasers
        • Prostatic Stents
        • Implants
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgery Centers
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Product Type:
        • Resectoscopes
        • Radiofrequency Ablation Devices
        • Urology Lasers
        • Prostatic Stents
        • Implants
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgery Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Resectoscopes
        • Radiofrequency Ablation Devices
        • Urology Lasers
        • Prostatic Stents
        • Implants
        • Others
      • By End User:
        • Hospitals
        • Ambulatory Surgery Centers
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
  • Olympus Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
  • Boston Scientific Corporation
  • KARL STORZ SE & Co. KG
  • Medifocus Inc.
  • NxThera, Inc.
  • ProArc Medical
  • Lisa Laser Products OHG
  • Richard Wolf Gmbh

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Mergers & Acquisitions and Investments
    • Start-Up Presence
    • Epidemiology
    • Impact Analysis
    • Regulatory Scenario
    • Pipeline Analysis
    • Technology Evolution
    • Benign Prostatic Hyperplasia Management Framework
  4. Global Benign Prostatic Hyperplasia Surgical Devices Market, By Product Type, 2015–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Resectoscopes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
    • Radiofrequency Ablation Devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
    • Urology Lasers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
    • Prostatic Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
    • Implants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
  5. Global Benign Prostatic Hyperplasia Surgical Devices Market, By End User, 2015–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017–2025, (US$ Mn)
  6. Global Benign Prostatic Hyperplasia Surgical Devices Market, By Region, 2015–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2025
    • North America
      • Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By End User, 2015–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015–2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  7. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Olympus Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • KARL STORZ SE & Co. KG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medifocus Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • NxThera, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ProArc Medical
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Lisa Laser Products OHG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Richard Wolf Gmbh
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 27 market data tables and 22 figures on "Benign Prostatic Hyperplasia Surgical Devices Market - Global forecast to 2025”.